A very little subset of patients diagnosed with interstitial nephritis have the tubulointerstitial nephritis and uveitis (TINU syndrome). A considerable number of cases have been documented in the pediatric nephrology and ophthalmology literature. We report a 12-year-old girl who presented with a history of allergic/drug-induced tubulointerstitial nephritis and diagnosed months later to have uveitis after stopping steroids. This considered a very rare combination and the diagnosis of tubulointerstitial nephritis and uveitis syndrome was established. She was treated successfully with topical steroid and topical cycloplegic agent for about 7 weeks. About 250 cases have been reported worldwide, and this is the first reported case in Jordan.
Introduction
Tubulointerstitial nephritis (TIN) is a primary injury of both renal tubules and interstitium leading to a decrease in renal function. The acute form is more common. More than 95% of cases result from infection or an allergic drug reaction.
Tubulointerstitial Nephritis and Uveitis Syndrome depicts a rare form of non-granulomatous bilateral The interstitium shows generalized edema with minimal fibrosis and dense infiltration by lymphocytes, plasma cells, macrophages, and eosinophils. The tubules show epithelial damage and luminal white blood cells. The blood vessels are normal. www.scholink.org/ojs/index.php/rhs Research in Health Science Vol. 5, No. 1, 2020 30
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The patient presented to our ophthalmology clinic with bilateral epiphora, photophobia, and eye redness. She was complaining of red-eye the week before, accordingly, she was diagnosed to have viral conjunctivitis and treated with lubricating eye drops by a general practitioner.
Upon examination, the best-corrected visual acuity was 20/40 for her right and left eyes. Slit-lamp examination showed severe limbal injection bilaterally with corneal edema, +4 anterior chamber cells, flare, fine diffuse endothelial precipitates, and severe inflammatory membrane clumped to both irides with posterior synechia. The patient was started on topical corticosteroids every two hours and topical cycloplegic eye drops three times a day then referred to her nephrologist to reassess. One week later the anterior chamber reaction dropped to +2 cells, the inflammatory membrane had nearly disappeared and the fundus exam was normal. After two weeks her eyes were quiet, her best-corrected vision was 20/20 for both eyes, and her labs were within normal limits. The topical cycloplegic agent was stopped and the topical corticosteroid was tapered over the next 4 weeks.
The diagnosis of tubulointerstitial nephritis and uveitis (TINU) syndrome was established and she was followed up regularly.
Discussion
Tubulointerstitial Nephritis and Uveitis (TINU) syndrome is a rare oculorenal inflammatory disease accounting for less than 1-2% of all patients presenting to ophthalmology (Mackensen & Billing, 2009 ).
The true prevalence is unknown exactly and supposedly be higher because undiagnosed cases are considered idiopathic. On average, TINU occurs in approximately 65% of patients with TIN (Mandeville, Levinson, & Holland, 2001) in whom renal tubular defects are found usually. The mean age of presentation is 15 years with female to male ratio 3:1 (Mandeville, Levinson, & Holland, 2001 ). There is an increased proportion of affected males in recent reports (Sinnamon, Courtney, & Harron, 2008) with a trend towards a male predominance in younger age groups (Yoshioka, Takemura, Kanasaki, Akano, & Maki, 1991) . There is no association with particular racial or ethnic groups, or geographical distribution (Mandeville, Levinson, & Holland, 2001; Mackensen et al., 2011) .
The cause of TINU is unknown but various associations had revealed in researches. Certain HLA genotypes (including HLA-DQA1and DRB1) increase the relative risk of developing TINU in certain populations (Yoshioka, Takemura, Kanasaki, Akano, & Maki, 1991; Mackensen et al., 2011) . In addition, medications have been implicated as antibiotics or NSAIDs. The drug causing hapten-induced cytokine production or hypersensitivity and immune reaction. Another possibility correlated to dysfunction or targeted disruption of similar enzymes in the renal tubule and ciliary epithelium.
The underlying mechanisms for TINU are not fully recognized yet. Limited data suggest that modified C-reactive protein (mCRP), an autoantigen common to both the uvea and renal tubular cells, may play a role in the pathogenesis (Tan et al., 2011) . In a study of 97 patients with various renal disorders and 40 healthy controls, the prevalence of immunoglobulin G (IgG) antibodies directed against CRP was significantly higher among nine patients with TINU syndrome (100%) than among those with Sjögren's associated interstitial nephritis (29%), drug-induced interstitial nephritis (36%), glomerulonephritis (5%), and healthy controls (0 percent) (Tan et al., 2011) . Another study by the same group proved that patients with TINU syndrome and late-onset uveitis had a higher level of mCRP compared with those with drug-induced interstitial nephritis (Li, Su, Chu, Li, & Yang, 2014) .
The inflammation in TINU syndrome is thought to be induced by T-lymphocyte mainly, based upon the histology. In contrast, immune cells in patients with TINU syndrome have a paradoxical suppression of cytokine production and a decrease in the peripheral immune response. This paradox is not unique to TINU, as the presence of increased tissue inflammation with concomitant suppression of peripheral immunity is also seen in patients with sarcoidosis (Gafter et al., 1993; Levinson et al., 2003) .
No identifiable risk factors are known at least in 50 percent of cases. In some patients, prior infection or the use of specific drugs (antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs)) has been implicated (Li, Su, Chu, Li, & Yang, 2014; Mandeville, Levinson, & Holland, 2001) . The Chinese herb, "Goreisan", was reported as a trigger (Suzuki et al., 2009) . Concurrent Chlamydia and Epstein-Barr virus infections have been described (Grefer et al., 1999; Stupp, Mihatsch, Matter, & Streuli, 1990) . TINU syndrome has also been reported in patients with autoimmune diseases like hypothyroidism, hypoparathyroidism, rheumatoid arthritis, and immunoglobulin G4 (IgG4)-related diseases (Catalano et al., 1989) .
Patients usually present with typical anterior uveitis symptoms like (eye pain, redness, and photophobia).
Symptoms of TIN are not always clear and include malaise, fever, fatigue, and loin pain or tenderness.
The general malaise usually precedes the ocular findings. The ocular symptoms can precede (21%) by up to two months (Yoshioka, Takemura, Kanasaki, Akano, & Maki, 1991) , occur concurrently (15%) or follow TIN (65%).
More than 80% of cases with bilateral acute, anterior, non-granulomatous uveitis, however, few cases of posterior uveitis and panuveitis were reported (Mackensen & Billing, 2009; Mandeville, Levinson, & Holland, 2001) . In 2006 a case of nodular scleritis preceding TINU syndrome in adults was reported indicating that episcleritis may be part of the ocular inflammation occurring in TINU syndrome (Daniel, Gangaputra, Kempen, & Jabs, 2006) . In 2001 Mandeville et al have published the evaluation criteria for the TINU syndrome (Mandeville, Levinson, & Holland, 2001 ) depend on the presence of acute interstitial nephritis and uveitis, without any underlying disease, in addition to the following: abnormal
